Pages that link to "Q70340479"
Jump to navigation
Jump to search
The following pages link to Immunosuppressive, antiviral and antitumor activities of cytarabine derivatives (Q70340479):
Displayed 16 items.
- Comparison of the Antiviral Effects of 5-Methoxymethyl-deoxyuridine with 5-Iododeoxyuridine, Cytosine Arabinoside, and Adenine Arabinoside (Q24562084) (← links)
- Antiviral Activities of Acyl Derivatives of 2,2′-Anhydro-1-β- d -Arabinofuranosylcytosine and 1-β- d -Arabinofuranosylcytosine in Cell Culture (Q28318082) (← links)
- Antiviral activity of O'-alkylated derivatives of cytosine arabinoside (Q28337067) (← links)
- Ara-C and derivatives as examples of immunosuppressive nucleoside analogs (Q34063514) (← links)
- Assessment of cytosine arabinoside as an antiviral agent in humans (Q34410864) (← links)
- MYC in oncogenesis and as a target for cancer therapies (Q37732974) (← links)
- Towards selectivity? approaches to the design of new anti-tumour agents—I (Q39620743) (← links)
- Towards selectivity? Approaches to the design of new anti-tumour agents-II (Q39864677) (← links)
- Immunosuppression — Agents, Procedures, Speculations and Prognosis (Q39923325) (← links)
- Effect of anti-herpesvirus drugs on human and bovine lymphoid function in vitro (Q39968192) (← links)
- Use of liposomes for the enhancement of the cytotoxic effects of cytosine arabinoside (Q40555492) (← links)
- Effects of Adenine Arabinoside on Cellular Immune Mechanisms in Humans (Q40943861) (← links)
- Linkages between changes in the 3D organization of the genome and transcription during myotube differentiation in vitro (Q41877709) (← links)
- Small lymphocyte phosphorylation of cytarabine—an organ and species survey (Q43995358) (← links)
- Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs (Q44768385) (← links)
- Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (Q69428716) (← links)